American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about NBT Bancorp (NASDAQ:NBTB) Given “Overweight” Rating at Stephens

NBT Bancorp (NASDAQ:NBTB) Given “Overweight” Rating at Stephens

Stephens reissued their overweight rating on shares of NBT Bancorp (NASDAQ:NBTB – Free Report) in a research report released on Tuesday morning, Benzinga reports. They currently have a $42.00 price target on the bank’s... More of this article »
Image about Caledonia Investments (LON:CLDN) Stock Passes Above Fifty Day Moving Average of $3,330.84

Caledonia Investments (LON:CLDN) Stock Passes Above Fifty Day Moving Average of $3,330.84

Caledonia Investments Plc (LON:CLDN – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 3,330.84 ($41.14) and traded as high as GBX 3,570 ($44.10).... More of this article »
Image about Circa Enterprises (CVE:CTO) Share Price Passes Above 50-Day Moving Average of $2.08

Circa Enterprises (CVE:CTO) Share Price Passes Above 50-Day Moving Average of $2.08

Circa Enterprises Inc. (CVE:CTO – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$2.08 and traded as high as C$2.08. Circa Enterprises... More of this article »
Image about Gainey Capital (CVE:GNC) Shares Pass Above 50 Day Moving Average of $0.08

Gainey Capital (CVE:GNC) Shares Pass Above 50 Day Moving Average of $0.08

Shares of Gainey Capital Corp. (CVE:GNC – Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.08 and traded as high as C$0.09. Gainey Capital shares... More of this article »
Image about Neurocrine Biosciences (NASDAQ:NBIX) Given Hold Rating at Needham & Company LLC

Neurocrine Biosciences (NASDAQ:NBIX) Given Hold Rating at Needham & Company LLC

Needham & Company LLC reiterated their hold rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report issued on Tuesday, Benzinga reports. A number of other research analysts have also weighed in... More of this article »
Image about BlackRock World Mining Trust (LON:BRWM) Shares Pass Above Fifty Day Moving Average of $520.94

BlackRock World Mining Trust (LON:BRWM) Shares Pass Above Fifty Day Moving Average of $520.94

BlackRock World Mining Trust plc (LON:BRWM – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 520.94 ($6.43) and traded... More of this article »
Image about Insight Enterprises (NASDAQ:NSIT) Given “Outperform” Rating at Barrington Research

Insight Enterprises (NASDAQ:NSIT) Given “Outperform” Rating at Barrington Research

Barrington Research reissued their outperform rating on shares of Insight Enterprises (NASDAQ:NSIT – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Barrington Research currently has... More of this article »
Image about Fundsmith Emerging Equities Trust (LON:FEET) Shares Cross Above Fifty Day Moving Average of $1,240.00

Fundsmith Emerging Equities Trust (LON:FEET) Shares Cross Above Fifty Day Moving Average of $1,240.00

Fundsmith Emerging Equities Trust plc (LON:FEET – Get Free Report) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1,240 ($15.32) and traded as high... More of this article »
Image about TRX Gold (TSE:TNX) Stock Passes Above 50 Day Moving Average of $15.39

TRX Gold (TSE:TNX) Stock Passes Above 50 Day Moving Average of $15.39

TRX Gold Co. (TSE:TNX – Get Free Report) (NYSE:TRX) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$15.39 and traded as high as C$46.31. TRX Gold shares last traded... More of this article »
Image about Intellia Therapeutics’ (NTLA) “Neutral” Rating Reaffirmed at Wedbush

Intellia Therapeutics’ (NTLA) “Neutral” Rating Reaffirmed at Wedbush

Wedbush reaffirmed their neutral rating on shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) in a research report report published on Tuesday, Benzinga reports. They currently have a $29.00 price target on the stock. A... More of this article »
Image about Inca One Gold (CVE:IO) Shares Pass Above 50 Day Moving Average of $0.41

Inca One Gold (CVE:IO) Shares Pass Above 50 Day Moving Average of $0.41

Inca One Gold Corp. (CVE:IO – Get Free Report)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.41 and traded as high as C$0.42. Inca One Gold... More of this article »
Image about Genesis Emerging Markets Fund (LON:GSS) Stock Price Crosses Above 50 Day Moving Average of $869.00

Genesis Emerging Markets Fund (LON:GSS) Stock Price Crosses Above 50 Day Moving Average of $869.00

Shares of Genesis Emerging Markets Fund (LON:GSS – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 869 ($10.73) and traded as high as GBX 874 ($10.80).... More of this article »
Image about Nextracker (NASDAQ:NXT) Price Target Lowered to $60.00 at Guggenheim

Nextracker (NASDAQ:NXT) Price Target Lowered to $60.00 at Guggenheim

Nextracker (NASDAQ:NXT – Free Report) had its price objective trimmed by Guggenheim from $73.00 to $60.00 in a report published on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities... More of this article »
Image about Redeia Corporación (OTCMKTS:RDEIY) Shares Pass Above Fifty Day Moving Average of $8.24

Redeia Corporación (OTCMKTS:RDEIY) Shares Pass Above Fifty Day Moving Average of $8.24

Redeia Corporación, S.A. (OTCMKTS:RDEIY – Get Free Report)’s share price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $8.24 and traded as high as $8.54. Redeia... More of this article »
Image about Onsemi (NASDAQ:ON) Price Target Lowered to $95.00 at Wells Fargo & Company

Onsemi (NASDAQ:ON) Price Target Lowered to $95.00 at Wells Fargo & Company

Onsemi (NASDAQ:ON – Free Report) had its price objective decreased by Wells Fargo & Company from $110.00 to $95.00 in a research report report published on Tuesday, Benzinga reports. Wells Fargo & Company currently... More of this article »